Interactive Chatbot for Cancer
(GIFTT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to develop and implement a methodology of digital tools paired with telemedicine to improve cascade testing for clinically significant germline mutations among family members of children with cancer who have a pathogenic or likely pathogenic(P/LP) germline variant in a cancer predisposition gene.
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive genetic counseling via digital tools and telemedicine
Follow-up
Participants are monitored for understanding of genetic information and psychosocial impact
What Are the Treatments Tested in This Trial?
Interventions
- Interactive Chatbot
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Genetic counseling via digital tools and telemedicine
Find a Clinic Near You
Who Is Running the Clinical Trial?
Abramson Cancer Center at Penn Medicine
Lead Sponsor
Emory University
Collaborator
Baylor College of Medicine
Collaborator
Fox Chase Cancer Center
Collaborator
National Cancer Institute (NCI)
Collaborator
Dana-Farber Cancer Institute
Collaborator
Ann & Robert H Lurie Children's Hospital of Chicago
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.